CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin (2007)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; DOREA, EGIDIO LIMA - HU
- Unidades: FCF; HU
- Subjects: POLIMORFISMO; EXPRESSÃO GÊNICA; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2007
- Source:
- Título: Clinical Chemistry
- ISSN: 0009-9147
- Volume/Número/Paginação/Ano: v. 53, n. 6, supl.S, p. A151, res.C-152, 2007
- Conference titles: AACC Annual Meeting
-
ABNT
WILLRICH, Maria Alice Vieira et al. CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 fev. 2026. , 2007 -
APA
Willrich, M. A. V., Hirata, M. H., Bernik, M. M. S., Dorea, E. L., Bertolami, M. C., Faludi, A. A., & Hirata, R. D. C. (2007). CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Willrich MAV, Hirata MH, Bernik MMS, Dorea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin. Clinical Chemistry. 2007 ; 53( 6): A151.[citado 2026 fev. 14 ] -
Vancouver
Willrich MAV, Hirata MH, Bernik MMS, Dorea EL, Bertolami MC, Faludi AA, Hirata RDC. CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin. Clinical Chemistry. 2007 ; 53( 6): A151.[citado 2026 fev. 14 ] - Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
